Bruce McAnally

FGBI Director McAnally buys 109,051 shares at $9.17 for $1,000.0K; 2 other insiders also bought within 14 days, cluster pattern despite unprofitable full fiscal year.

Bruce McAnally, a director, acquired 109,051 shares at $9.17 on 2026-04-30 for $1,000.0K, increasing his holdings to 441,587 shares (+32.8% vs pre-transaction). This purchase coincides with a cluster pattern: 2 other insiders also bought within the past 14 days. While the stock has appreciated 17.1% over the past 30 days and 28.1% over 90 days, McAnally's same-ticker track record at FGBI shows mixed timing outcomes—only 1 of 4 prior buys yielded positive 90-day returns. Notably, the company was unprofitable over its most recent full fiscal year despite current net income of $2.7M, introducing fundamental uncertainty about the durability of recent price momentum.

Director McAnally bought 32,176 shares of FGBI at $7.77 on 2026-03-31, adding $250.0K; stock is unprofitable, 2 other insiders also bought recently.

McAnally Bruce, a director, purchased 32,176 shares at $7.77 on 2026-03-31, increasing his stake by 10.7% to 332,536 shares total. The purchase occurs while First Guaranty Bancshares reported a full-year net income of $-45.0M, indicating unprofitability. A cluster pattern is evident: 2 other insiders also bought within the past 14 days. Historically at this ticker, McAnally's prior buy on 2025-12-31 achieved a 90-day return of +50.4%, but his 2025-09-30 buy returned -35.5% over 90 days; across all four same-ticker prior trades, only 1 of 4 achieved positive 90-day returns, suggesting mixed timing results in this stock.

Director McAnally buys 92.6K shares of FGBI at $5.40 (+44.6% of holdings); stock down -52.9% from 52-week high, fundamentals weak ($-45.0M net income).

Bruce McAnally, a Director, purchased 92,600 shares at $5.40 on 2025-12-31, increasing holdings by 44.6% to 300,360 shares total. This represents a substantial position increase at a price $0.02 below current levels ($5.38), yet the stock is trading -52.9% from its 52-week high of $11.43. The company's fundamentals show net income of $-45,003,000.00 and a depressed market cap of $82,598,854.86. Notably, two other insiders also purchased shares within the past 14 days, forming a cluster buy pattern. However, McAnally's own track record at this ticker has been unfavorable: his three prior FGBI purchases showed 90-day results of -35.5%, -0.4%, and -4.7%, with a 0% win rate at the 90-day mark, suggesting a pattern of ill-timed entry decisions at this specific stock.

Director Bruce McAnally buys 31,056 shares of FGBI at $8.05; stock -46.7% from 52-week high; cluster buy pattern with 2 other insiders in 14 days

Director Bruce McAnally purchased 31,056 shares at $8.05 on 2025-09-30, increasing his holdings by 17.6% to 207,760 shares. The stock is trading at $7.86, down -46.7% from the 52-week high of $14.75, and McAnally's two prior purchases at FGBI in 2025 each showed positive 30-day returns but failed to time the longer-term direction—the June buy returned +6.8% in 30 days but -0.4% over 90 days, and the March buy returned +11.0% in 30 days but -4.7% over 90 days. His cross-ticker track record shows 0% 90-day win rate across 2 prior buys. A cluster pattern is present: 2 other insiders also bought within the past 14 days. The company posted a net loss of -7,303,000.00 and trades at a P/E of 9.70. The combination of repeated accumulation at a depressed price point, continued fundamental weakness, and repeated failure of prior buys to sustain gains warrants review of whether this purchase reflects access to positive information or simply represents systematic averaging into a troubled position.

Director McAnally Bruce buys 30,865 shares of FGBI at $8.10; 4 insiders bought within 14 days as stock trades -44.3% from 52-week high.

McAnally Bruce purchased 30,865 shares at $8.10 on 2025-06-30, increasing his holdings by 21.2% to 176,704 shares total, coinciding with a cluster of 4 other insider buys within the past 14 days. The stock currently trades at $8.22, down 44.3% from its 52-week high of $14.75, presenting a depressed price environment relative to recent peaks. However, the company reports a net loss of $6,166,000.00 and carries a P/E of 26.52, signaling fundamental weakness that complicates any valuation narrative. His prior FGBI buy on 2025-03-31 delivered positive 30-day returns (+11.0%) but negative 90-day returns (-4.7%), establishing a pattern of near-term strength followed by deterioration; this current purchase occurs in that same weakening context.

Director McAnally bought 24,615 shares of FGBI at $8.47; stock now -47.6% from 52-week high; 5 other insiders also bought in past 14 days.

Director McAnally purchased 24,615 shares at $8.47 on 2025-03-31, increasing his holdings by 20.3% to 145,839 shares. This acquisition occurs in a significant cluster context—5 other insiders also bought within the past 14 days—suggesting coordinated insider confidence. However, the timing warrants scrutiny: FGBI trades at $7.73 currently, down 47.6% from its 52-week high of $14.75 and down 31.6% over the past 90 days, meaning McAnally purchased shares well above the current market price. With a low P/E of 6.04 and market cap of $96.7M, the company is not flush with earnings ($1.9M net income), yet multiple insiders are accumulating despite steep recent declines. This cluster buy pattern in a depressed price environment, coupled with fundamental weakness, merits examination of whether insiders perceive value or face other incentives.